Press Сentre

Company news

Per page:
BIOTECHMED 2019 Forum that involved representatives of ChemRar Group and international accelerator biobridge-2019, comprised the finals of the innovative pharmaceuticals and medical equipment contest titled Startup Rally. Declared the best from 150 applicants, 36 finalist teams from 12 regions of Russia presented their projects. Project KFU-05 ...
27.11.2019
The international accelerator biobridge-2019 has established a special nomination for the finalists of the Startup Rally competition in the field of innovative drugs and medical devices — the winner will be invited to the Demo Day at biobridge-2019 in Vienna (Austria), where the team will be able to present their projects to Russian and European ...
27.11.2019
On July 25, 2019, during the Selection Day at the Boiling Point ASI in Moscow, we will finally choose the strongest projects of the acceleration program biobridge-2019. 25+ teams invited to the Selection Day will showcase their developments to our expert jury during the pitch session, and the best 10–15 teams will be picked up for the program. ...
27.11.2019
Russian Venture Company announced the start of selecting a managing company for a ₽4.5-billion fund founded jointly with the Ministry of Industry and Trade of the Russian Federation for the purposes of supporting high-tech projects concerned with developing and manufacturing innovative drugs, medical products, and software. On July 3, a ...
27.11.2019
June 27 was the pre-selection day of biobridge 2019 that brought the first on-site event organized to introduce teams and pre-select projects to the acceleration program. During the event, 20 projects across various fields of medicine — oncology, radiology, women’s health, cardiology, etc. — were presented. Those participants who could not attend ...
27.11.2019
Today, on May 31, 2019, the finale of the open competition for development teams and start-ups, which create drug discovery & development solutions using artificial intelligence (AI) technologies, took place at “Boiling Point ASI”. The competition was organized by ChemRar Group together with the Moscow Institute of Physics and Technology and ...
27.11.2019
On May 17, at the Headquarters of the State Hermitage, within the framework of the 9th Saint Petersburg International Legal forum, the 2030 Strategy for Developing the Pharmaceutical Industry of Russia was discussed. The session involved First Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb, CEO of Sintez OJSC Sergey ...
27.11.2019
ChemRar Research Institute invites partners to use the new online form that helps quickly order the individual compound synthesis: group’s 29-year experience in the contract-based synthesis of small molecules, advanced approaches, and cutting-edge equipment are what help find an optimal solution for your tasks. Get an individual offer from 20+ ...
27.11.2019
Avineuro Project from ChemRar Group and organization Support of Patients with Alzheimer’s Disease and Their Families announced the launch of the educational online platform Memory Help for families of those suffering from dementia. The first group of the online school will start learning on April 25 and finish on June 2, 2019. Memory Help’s ...
27.11.2019
On April 3, 2019, the first meeting of the NeuroNet team was held at the Ministry of Education and Science of the Russian Federation. The team’s mission is forming the globally-competitive Russian segment of the NeuroNet market by 2035, ensuring the emergence of at least 10 national “champion companies”. The meeting was hosted by co-executives ...
27.11.2019
On March 14–15, 2019, the key sponsors of the acceleration program BioBridge-2019 — representatives of ChemRar Group and RDI Group — conducted several meetings and negotiations with Austrian partners, including Vienna Business Agency, which provides comprehensive support to companies willing to run business in Austria, and also visited the ...
27.11.2019
ChemRar Group and RDI group with the support of Neuronet industry union announce the launch of the first Russian international acceleration program BioBridge-2019 to support research and development projects for innovative pharmaceuticals and treatment methods. The Accelerator will include a competitive selection of the most advanced ...
27.11.2019